• Home

Edition

Skip to content
The Conversation
Edition:
  • Africa
  • Australia
  • Brasil
  • Canada
  • Canada (français)
  • Català
  • España
  • France
  • Global
  • Indonesia
  • New Zealand
  • United Kingdom
  • United States
s
Newsletters
The Conversation
Academic rigour, journalistic flair

Kellia Chiu

3

Articles

0

Comments
  • Associate Lecturer, School of Pharmacy and Charles Perkins Centre, University of Sydney
Profile Articles
Pixabay/Pexels
July 19, 2026

How drug companies are playing hardball with Australia’s PBS

Barbara Mintzes, University of Sydney; Ashleigh Hooimeyer, University of Sydney, and Kellia Chiu, University of Sydney

International drug companies are threatening to remove medicines from the market if Australia doesn’t offer them a better price. Here’s what’s at stake.
Shutterstock
December 3, 2020

Should Australians be worried about waiting for a COVID vaccine when the UK has just approved Pfizer’s?

Joel Lexchin, University of Toronto; Barbara Mintzes, University of Sydney; Kellia Chiu, University of Sydney, and Lisa Parker, University of Sydney

Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
Shutterstock
November 17, 2020

You may be able to buy a COVID vaccine ahead of the government rollout. But jumping the queue comes at a price

Barbara Mintzes, University of Sydney; Joel Lexchin, University of Toronto; Kellia Chiu, University of Sydney, and Zhicheng (Jeff) Wang, University of Sydney

A private market should have no place in the rollout of a COVID vaccine.
  • Location: Sydney, Australia
  • Website
  • BlueSky: @kelliachiu.bsky.social
  • Article Feed
  • ORCID
  • Joined November 12, 2020
Institution logo of University of Sydney
  • Editorial Policies
  • Community standards
  • Republishing guidelines
  • Analytics
  • Our feeds
  • Get newsletter
  • Who we are
  • Our charter
  • Partners and funders
  • Resource for media
  • Contact us
Privacy policy Consent preferences Terms and conditions Corrections

Copyright © 2010–2026, The Conversation Media Group Ltd